Q2 2015 Holdings
Filed 2015-08-12 | 29 holdings | $340.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc.(AGIO) | COM | 00847X104 | $221.2M | 1,989,921 | 65.0% |
| Alnylam Pharmaceuticals Inc.(ALNY) | COM | 02043Q107 | $115.7M | 965,499 | 34.0% |
| Celgene Corp.(CELG) | COM | 151020104 | $412.5K | 3,564,298 | 0.1% |
| Incyte Corp.(INCY) | COM | 45337C102 | $389.8K | 3,740,406 | 0.1% |
| Isis Pharmaceuticals Inc. | COM | 464330109 | $341.2K | 5,929,426 | 0.1% |
| Gilead Sciences Inc.(GILD) | COM | 375558103 | $317.9K | 2,715,596 | 0.1% |
| Radius Health Inc. | COM | 750469207 | $265.5K | 3,922,140 | 0.1% |
| Vertex Pharmaceuticals Inc.(VRTX) | COM | 92532F100 | $164.8K | 1,334,445 | 0.0% |
| Neurocrine Biosciences Inc.(NBIX) | COM | 64125C109 | $153.9K | 3,221,552 | 0.0% |
| Medivation Inc. | COM | 58501N101 | $147.4K | 1,290,556 | 0.0% |
| Alexion Pharmaceuticals Inc.(ALXN) | COM | 015351109 | $140.5K | 777,428 | 0.0% |
| Halozyme Therapeutics Inc.(HALO) | COM | 40637H109 | $137.2K | 6,077,168 | 0.0% |
| Receptos Inc. | COM | 756207106 | $126.4K | 665,272 | 0.0% |
| Regeneron Pharmaceuticals Inc.(REGN) | COM | 75886F107 | $101.0K | 198,000 | 0.0% |
| Novavax Inc. | COM | 670002104 | $91.1K | 8,180,000 | 0.0% |
| Tetraphase Pharmaceuticals Inc. | COM | 88165N105 | $71.5K | 1,507,114 | 0.0% |
| Alder Biopharmaceuticals(ALDR1EUR) | COM | 014339105 | $61.2K | 1,155,150 | 0.0% |
| Puma Biotechnology Inc.(PBYI) | COM | 74587V107 | $60.9K | 521,991 | 0.0% |
| Cempra Inc. | COM | 15130J109 | $60.7K | 1,766,900 | 0.0% |
| PTC Therapeutics Inc.(PTCT) | COM | 69366J200 | $60.3K | 1,252,912 | 0.0% |
| Clovis Oncology Inc.(CLVSEUR) | COM | 189464100 | $54.3K | 618,188 | 0.0% |
| Tesaro Inc. | COM | 881569107 | $53.2K | 904,582 | 0.0% |
| Intercept Pharmaceuticals(ICPTUSD) | COM | 45845P108 | $43.6K | 180,719 | 0.0% |
| Infinity Pharmaceuticals Inc.(INFIQ) | COM | 45665G303 | $29.6K | 2,700,737 | 0.0% |
| Juno Therapeutics, Inc. | COM | 48205A109 | $24.0K | 450,000 | 0.0% |
| Kite Pharma, Inc. | COM | 49803L109 | $21.3K | 350,000 | 0.0% |
| Achillion Pharmaceuticals Inc.(ACHNEUR) | COM | 00448Q201 | $11.3K | 1,279,340 | 0.0% |
| Theravance Inc. | COM | 88338T104 | $6.0K | 331,594 | 0.0% |
| Theravance Biopharma Inc.(TBPH) | COM | G8807B106 | $4.7K | 359,190 | 0.0% |